Organization
MRC/UVRI and LSHTM Uganda Research Unit
3 clinical trials
Clinical trial
A Phase IIb Three-arm, Two-stage HIV Prophylactic Vaccine Trial With a Second Randomisation to Compare TAF/FTC to TDF/FTC as Pre-exposure ProphylaxisStatus: , Estimated PCD: 2024-12-31
Clinical trial
Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa: a Phase 3b, Open-label, Hybrid Type 2 Implementation and Effectiveness TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Phase 3b Randomised, Multicentre, Open-label Study Evaluating the Effectiveness of Switching to Two-monthly Long-acting Injectable Cabotegravir and Rilpivirine From First-line Oral Antiretroviral Therapy in HIV-1 Positive Virologically Suppressed Adults With a History of, or at Risk of, Sub-optimal HIV Control in Sub-Saharan AfricaStatus: Recruiting, Estimated PCD: 2024-11-01